Nifty
:
24252.00
Sensex
:
77540.83
20.15 (0.08%)
3.11 (0.00%)
Nifty
Sensex
:
:
24252.00
77540.83
20.15 (0.08%)
3.11 (0.00%)

Alembic Ltd.

Pharmaceuticals & Drugs - API

Rating :
68/99

BSE: 506235 | NSE: ALEMBICLTD

NSE BSE
92.73
21-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  92
  •  93.2
  •  90.42
  •  91.63
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  636995
  •  58659707.78
  •  108.5
  •  70.46

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,381.14
  • 7.43
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,388.49
  • 2.59%
  • 0.97

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.88%
  • 0.64%
  • 22.23%
  • FII
  • DII
  • Others
  • 1.25%
  • 0.00%
  • 5.00%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.01
  • 25.13
  • 15.07

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.67
  • 45.28
  • 9.65

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.44
  • 7.88
  • 10.68

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.01
  • 9.14
  • 8.74

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.13
  • 1.08
  • 1.20

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 29.42
  • 24.12
  • 19.71

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
48.74
49.75
-2.03%
60.04
60.27
-0.38%
74.34
57.92
28.35%
55.86
52.91
5.58%
Expenses
33.29
30.18
10.30%
39.83
32.95
20.88%
46.90
31.52
48.79%
32.62
33.34
-2.16%
EBITDA
15.45
19.57
-21.05%
20.21
27.32
-26.02%
27.44
26.40
3.94%
23.24
19.57
18.75%
EBIDTM
31.70%
39.34%
33.66%
45.33%
36.91%
45.58%
41.60%
36.99%
Other Income
5.97
3.59
66.30%
2.14
2.96
-27.70%
2.31
4.37
-47.14%
64.92
65.61
-1.05%
Interest
0.60
0.59
1.69%
0.57
0.62
-8.06%
0.55
0.69
-20.29%
0.56
0.67
-16.42%
Depreciation
3.48
2.79
24.73%
3.34
2.75
21.45%
3.44
2.69
27.88%
2.82
2.68
5.22%
PBT
17.34
19.78
-12.34%
18.44
26.91
-31.48%
25.76
27.39
-5.95%
84.78
81.83
3.61%
Tax
1.64
1.98
-17.17%
8.83
3.17
178.55%
3.29
1.30
153.08%
8.72
4.52
92.92%
PAT
15.70
17.80
-11.80%
9.61
23.74
-59.52%
22.47
26.09
-13.88%
76.06
77.31
-1.62%
PATM
32.21%
35.78%
16.01%
39.39%
30.23%
45.04%
136.16%
146.12%
EPS
2.53
2.40
5.42%
2.61
2.67
-2.25%
2.34
2.55
-8.24%
5.00
4.71
6.16%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
238.98
239.99
221.89
157.49
127.24
78.22
73.52
73.93
123.81
125.30
147.16
Net Sales Growth
8.21%
8.16%
40.89%
23.77%
62.67%
6.39%
-0.55%
-40.29%
-1.19%
-14.85%
 
Cost Of Goods Sold
50.93
76.44
69.17
48.95
41.12
22.62
22.24
31.71
66.95
78.50
96.33
Gross Profit
188.05
163.55
152.72
108.53
86.13
55.60
51.28
42.22
56.86
46.79
50.83
GP Margin
78.69%
68.15%
68.83%
68.91%
67.69%
71.08%
69.75%
57.11%
45.93%
37.34%
34.54%
Total Expenditure
152.64
149.84
128.18
100.62
86.91
64.29
63.09
70.79
106.46
114.19
140.45
Power & Fuel Cost
-
2.74
2.34
1.18
2.02
0.15
0.42
0.91
2.34
1.11
5.46
% Of Sales
-
1.14%
1.05%
0.75%
1.59%
0.19%
0.57%
1.23%
1.89%
0.89%
3.71%
Employee Cost
-
37.44
27.31
23.03
24.04
21.47
22.60
20.79
20.52
19.64
22.83
% Of Sales
-
15.60%
12.31%
14.62%
18.89%
27.45%
30.74%
28.12%
16.57%
15.67%
15.51%
Manufacturing Exp.
-
10.84
11.25
10.92
7.02
8.30
5.91
5.99
7.11
6.08
7.11
% Of Sales
-
4.52%
5.07%
6.93%
5.52%
10.61%
8.04%
8.10%
5.74%
4.85%
4.83%
General & Admin Exp.
-
11.80
12.24
11.85
8.90
9.12
6.63
8.30
7.15
6.80
6.48
% Of Sales
-
4.92%
5.52%
7.52%
6.99%
11.66%
9.02%
11.23%
5.77%
5.43%
4.40%
Selling & Distn. Exp.
-
4.41
1.84
2.19
1.90
0.69
0.92
0.87
0.11
0.34
0.90
% Of Sales
-
1.84%
0.83%
1.39%
1.49%
0.88%
1.25%
1.18%
0.09%
0.27%
0.61%
Miscellaneous Exp.
-
6.16
4.03
2.50
1.90
1.93
4.37
2.23
2.28
1.72
0.90
% Of Sales
-
2.57%
1.82%
1.59%
1.49%
2.47%
5.94%
3.02%
1.84%
1.37%
0.90%
EBITDA
86.34
90.15
93.71
56.87
40.33
13.93
10.43
3.14
17.35
11.11
6.71
EBITDA Margin
36.13%
37.56%
42.23%
36.11%
31.70%
17.81%
14.19%
4.25%
14.01%
8.87%
4.56%
Other Income
75.34
73.28
74.89
54.77
64.26
89.18
10.92
93.54
30.17
37.02
30.97
Interest
2.28
2.28
2.47
1.11
0.47
0.39
0.36
0.29
0.22
0.17
0.16
Depreciation
13.08
12.39
10.63
7.84
6.72
4.86
3.94
3.23
2.63
3.78
5.09
PBT
146.32
148.76
155.50
102.69
97.41
97.86
17.04
93.17
44.67
44.18
32.44
Tax
22.48
22.83
10.93
9.82
6.18
11.66
3.20
0.13
3.59
2.39
-0.86
Tax Rate
15.36%
15.35%
7.03%
9.56%
7.12%
11.91%
18.78%
0.14%
8.04%
5.41%
-3.23%
PAT
123.84
125.93
144.57
92.87
80.62
86.19
13.84
93.03
41.08
41.78
27.49
PAT before Minority Interest
123.84
125.93
144.57
92.87
80.62
86.19
13.84
93.03
41.08
41.78
27.49
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
51.82%
52.47%
65.15%
58.97%
63.36%
110.19%
18.82%
125.84%
33.18%
33.34%
18.68%
PAT Growth
-14.56%
-12.89%
55.67%
15.19%
-6.46%
522.76%
-85.12%
126.46%
-1.68%
51.98%
 
EPS
4.82
4.90
5.63
3.62
3.14
3.36
0.54
3.62
1.60
1.63
1.07

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
2,445.09
2,338.59
2,185.56
2,078.03
2,496.58
2,297.03
1,418.04
1,208.53
1,085.77
911.43
Share Capital
51.36
51.36
51.36
51.36
51.36
51.36
51.36
51.36
53.41
53.41
Total Reserves
2,393.73
2,287.23
2,134.21
2,026.68
2,445.23
2,245.67
1,366.69
1,157.17
1,032.37
858.02
Non-Current Liabilities
43.12
53.94
52.89
42.74
67.60
52.52
6.88
8.52
14.15
12.61
Secured Loans
6.61
10.67
7.39
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
3.72
2.44
1.91
1.21
1.10
0.83
0.70
0.72
0.80
0.78
Current Liabilities
120.68
127.59
96.11
89.56
67.76
59.41
45.80
48.80
59.12
68.34
Trade Payables
23.84
28.26
31.02
17.38
19.27
17.81
12.99
24.75
16.42
14.76
Other Current Liabilities
45.81
55.39
33.10
45.05
35.54
30.67
22.07
8.07
31.82
39.20
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.28
0.00
0.00
0.00
0.00
Short Term Provisions
51.02
43.94
31.99
27.13
12.96
10.66
10.74
15.97
10.89
14.38
Total Liabilities
2,608.89
2,520.12
2,334.56
2,210.33
2,631.94
2,408.96
1,470.72
1,265.85
1,159.04
992.38
Net Block
170.00
135.38
130.59
131.88
133.55
133.74
130.68
131.16
132.28
147.60
Gross Block
193.41
156.66
151.54
151.21
151.21
149.90
145.37
144.59
144.33
158.33
Accumulated Depreciation
23.40
21.28
20.95
19.33
17.66
16.16
14.69
13.44
12.05
10.73
Non Current Assets
2,392.27
2,298.14
2,191.38
2,032.45
2,488.63
2,306.87
1,307.90
1,167.08
972.32
801.10
Capital Work in Progress
1.50
0.00
1.10
0.13
0.19
37.27
18.69
22.26
31.64
0.16
Non Current Investment
1,877.52
1,844.95
1,774.65
1,708.16
2,182.01
2,030.58
1,078.88
957.76
792.85
627.47
Long Term Loans & Adv.
36.56
36.22
36.22
1.22
6.54
1.95
0.86
0.17
0.38
2.05
Other Non Current Assets
4.97
8.02
10.64
1.64
2.67
3.52
0.00
0.00
0.00
0.00
Current Assets
216.62
221.99
143.19
177.89
143.32
102.09
162.82
98.68
185.41
191.28
Current Investments
96.62
55.10
11.34
45.40
25.84
16.59
53.71
43.46
119.85
104.76
Inventories
52.24
99.39
92.60
88.61
86.87
54.28
35.41
35.33
32.41
50.61
Sundry Debtors
31.90
29.97
19.76
23.45
15.22
13.81
8.98
13.51
25.29
21.60
Cash & Bank
3.29
4.37
2.47
1.90
1.85
6.57
58.85
2.01
0.84
2.32
Other Current Assets
32.57
6.86
3.92
8.95
13.54
10.84
5.86
4.38
7.02
11.98
Short Term Loans & Adv.
27.26
26.30
13.10
9.57
9.65
8.73
4.38
2.59
6.34
9.88
Net Current Assets
95.94
94.40
47.08
88.32
75.56
42.68
117.03
49.88
126.28
122.94
Total Assets
2,608.89
2,520.13
2,334.57
2,210.34
2,631.95
2,408.96
1,470.72
1,265.76
1,157.73
992.38

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
120.07
86.37
22.69
38.85
-17.75
-2.18
6.54
21.51
23.58
51.63
PBT
148.76
155.50
102.69
86.80
97.86
17.04
93.17
44.67
44.18
26.63
Adjustment
-49.54
-52.98
-42.09
-52.87
-78.66
1.65
-85.70
-20.51
-28.85
-20.86
Changes in Working Capital
40.22
-0.60
-38.47
11.44
-27.90
-18.64
0.60
1.99
11.89
46.06
Cash after chg. in Working capital
139.44
101.93
22.12
45.37
-8.70
0.05
8.06
26.15
27.22
51.83
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-19.38
-15.56
0.57
-6.52
-9.04
-2.23
-1.53
-4.64
-3.64
-0.20
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-53.86
-26.58
25.84
7.30
18.85
-34.87
56.72
71.67
-22.40
-46.69
Net Fixed Assets
-38.25
-4.02
-1.30
0.06
35.77
-23.11
2.79
9.12
-17.43
213.26
Net Investments
64.77
-3.03
92.03
223.30
-144.79
-383.89
7.99
70.53
-87.29
-54.55
Others
-80.38
-19.53
-64.89
-216.06
127.87
372.13
45.94
-7.98
82.32
-205.40
Cash from Financing Activity
-67.50
-58.34
-48.19
-46.39
-5.82
-15.36
-6.41
-92.01
-2.66
-4.96
Net Cash Inflow / Outflow
-1.30
1.45
0.33
-0.24
-4.72
-52.41
56.85
1.17
-1.48
-0.02
Opening Cash & Equivalents
2.71
1.26
0.93
1.17
5.89
58.30
2.01
0.84
2.32
2.34
Closing Cash & Equivalent
1.41
2.71
1.26
0.93
1.17
5.89
58.85
2.01
0.84
2.32

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
95.22
91.07
85.11
80.93
97.23
89.45
55.22
47.06
40.66
34.13
ROA
4.91%
5.96%
4.09%
3.33%
3.42%
0.71%
6.80%
3.39%
3.88%
2.94%
ROE
5.27%
6.39%
4.36%
3.52%
3.60%
0.75%
7.08%
3.58%
4.18%
3.21%
ROCE
6.28%
6.95%
4.86%
3.82%
4.10%
0.94%
7.12%
3.91%
4.44%
3.12%
Fixed Asset Turnover
1.37
1.44
1.04
0.84
0.52
0.30
0.34
0.68
0.80
0.58
Receivable days
47.05
40.90
50.08
55.47
67.74
56.58
55.52
57.19
67.34
59.14
Inventory Days
115.31
157.91
210.00
251.69
329.34
222.67
174.64
99.84
119.22
149.70
Payable days
124.39
156.42
180.44
162.67
299.17
252.73
120.48
74.61
55.73
40.49
Cash Conversion Cycle
37.96
42.40
79.64
144.48
97.90
26.52
109.68
82.42
130.83
168.35
Total Debt/Equity
0.00
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
66.29
63.93
93.63
187.54
252.50
48.08
324.49
207.64
261.78
169.23

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Alembic - Quarterly Results
    12th Aug 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.